Myriad Genetics Europe


Myriad Genetics Europe is owned by Myriad Genetics.

Myriad Genetics is one of the...

Myriad Genetics is a company listed under the stock ticker MYGN (US).

Myriad Genetics has a direct presence in 2 countries.

Myriad Genetics has 4 subsidiaries including GeneSight, Myriad Genetics Europe and Myriad RBM.

They are in:


View the org chart displaying its 5 main executives

Most searched biographies at Myriad Genetics Europe
Popular executive movements at Myriad Genetics
  • Dale Muzzey, who was Vice President of Bioinformatics, is promoted to Interim Chief Scientific Officer and Senior Vice President, Research and Development  (posted on January 5 2022).
  • Jerry Lanchbury, Chief Scientific Officer, is retiring  (posted on January 5 2022).
  • Nicole Lambert, who was President, Myriad Oncology, is promoted to Chief Operating Officer  (posted on December 15 2021).

Create an alert
to follow the executive moves at Myriad Genetics Europe.


Myriad Genetics has 2,080 competitors including Neptune Wellness Solutions (Canada), Bonesupport (Sweden) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >


Press releases by Myriad Genetics Europe
Social media about Myriad Genetics Europe

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.